• 1
    Franchini G. Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type 1 infection. Blood 1995; 86: 361939.
  • 2
    Sagara Y, Inoue Y, Shiraki H, Jinno A, Hoshino H, Maeda Y. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins using synthetic peptides. J Virol 1996; 70: 15649.
  • 3
    Sagara Y, Ishida C, Inoue Y, Shiraki H, Maeda Y. 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. J Virol 1998; 72: 53541.
  • 4
    Sagara Y, Shiraki H. How does lipid in plasma membrane participate in viral infection? Res Adv Virol 2002; 2: 6981.
  • 5
    Ferrarini M, Heltai S, Zocchi MR, Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer 1992; 51: 6139.
  • 6
    Gehrmann M, Brunner M, Pfister K, Reichle A, Kremmer E, Multhoff G. Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs. Clin Cancer Res 2004; 10: 335464.
  • 7
    Lebret T, Watson RW, Molinie V, O'neill A, Gabriel C, Fitzpatrick JM, Botto H. Heat shock proteins HSP27, HSP60, HSP70 and HSP90: expression in bladder carcinoma. Cancer 2003; 98: 9707.
  • 8
    Tanaka Y, Lee Z, Shiraki H, Shida H, Tozawa H. Identification of a neutralizing epitope on the envelope gp46 antigen of human T-cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol 1991; 146: 35460.
  • 9
    Washitani Y, Kuroda N, Shiraki H, Itoyama Y, Sata H, Ohshima K, Kiyokawa H, Maeda Y. Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type 1 detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens. J Clin. Microbiol 1992; 30: 28790.
  • 10
    Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; i: 40710.
  • 11
    Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia cells. Ann Neural 1987; 21: 11722.
  • 12
    Vernant JC, Maurs L, Gessain A, Barin F, Gout O, Delaporte JM, Sanhadji K, Baisson G, de The G. Endemic tropical spatic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neural 1987; 21: 12330.
  • 13
    Nakamura M, Kuroki M, Kira J, Itoyama Y, Shiraki H, Kuroda N, Washitani Y, Nakano S, Nagafuchi S, Anzai K, Tatsumoto T, Esaki T, Maeda Y, Niho Y. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP. J Neuroimmunol 1991; 35; 16777.
  • 14
    Sagara Y, Inoue Y, Kojima E, Ishida C, Shiraki H, Maeda Y. HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex. AIDS Res Hum. Retroviruses 2000; 16: 17014.
  • 15
    Shiraki H, Sagara Y, Inoue Y. Cell-to-cell transmission of HTLV-1. Gann Monogr Cancer Res 2003; 50: 30316.
  • 16
    Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nature Rev Immunol 2002; 2: 18594.
  • 17
    Pockley AD. Heat shock proteins as regulators of the immune response. Lancet 2003; 362: 46976.
  • 18
    Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 139.
  • 19
    Srivastava PK. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune response. Ann Rev Immunol 2002; 20: 395425.